Molecular Targeted Therapies in Glioblastoma Multiforme: A Systematic Overview of Global Trends and Findings

This systematic review assesses current molecular targeted therapies for glioblastoma multiforme (GBM), a challenging condition with limited treatment options. Using PRISMA methodology, 166 eligible studies, involving 2526 patients (61.49% male, 38.51% female, with a male-to-female ratio of 1.59/1),...

Description complète

Détails bibliographiques

Auteurs principaux:	Emir Begagić, Ragib Pugonja, Hakija Bečulić, Amila Čeliković, Lejla Tandir Lihić, Samra Kadić Vukas, Lejla Čejvan, Rasim Skomorac, Edin Selimović, Belma Jaganjac, Fatima Juković-Bihorac, Aldin Jusić, Mirza Pojskić
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2023-11-01
Collection:	Brain Sciences
Sujets:	target therapy glioblastoma central nervous system molecular biology
Accès en ligne:	https://www.mdpi.com/2076-3425/13/11/1602
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!